Some recent analyst ratings include

• 11/1/2019-
  ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy rating reiterated by HC Wainwright with a $60.00 price target
• 10/24/2019-
  ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has coverage initiated with a Market Perform rating and $44.00 price target
• 10/1/2019-
  ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has coverage initiated with a Outperform rating and $60.00 price target
• 9/13/2019-
  ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets upgraded to Outperform by Svb Leerink with a price target of $50.00
• 9/13/2019-
  ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets upgraded to Outperform by Leerink Swann with a price target of $50.00
• 9/10/2019-
  ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy rating reiterated by JPMorgan Chase & Co.

• On 10/15/2019 Eric Alejandro Miller, Insider, sold 147 with an average share price of $39.65 per share and the total transaction amounting to $5,828.55.
• On 10/15/2019 Michael J Yang, EVP, sold 877 with an average share price of $39.65 per share and the total transaction amounting to $34,773.05.
• On 10/15/2019 Srdjan R Stankovic, President, sold 1,031 with an average share price of $39.65 per share and the total transaction amounting to $40,879.15.
• On 10/15/2019 Stephen Davis, CEO, sold 2,983 with an average share price of $39.65 per share and the total transaction amounting to $118,275.95.
• On 10/9/2019 Stephen Davis, CEO, sold 29,792 with an average share price of $40.00 per share and the total transaction amounting to $1,191,680.00.
• On 9/20/2019 Bros. Advisors Lp Baker, Director, bought 1,562,500 with an average share price of $40.00 per share and the total transaction amounting to $62,500,000.00.
• On 9/11/2019 Eric Alejandro Miller, Insider, sold 4,645 with an average share price of $41.18 per share and the total transaction amounting to $191,281.10.

Recent Trading Activity for